Zug/Vancouver/New York - Absci is establishing an innovation center in the Greater Zurich Area. The existing talent and technology ecosystem in the region should help the US biotech firm to bring new drugs more rapidly to market with the help of Artificial Intelligence.

Absci, a biotechnology firm based in Vancouver in the US State of Washington and in New York City, has opted for Zug as the location for its new innovation center. The biotech firm specializes in the area of generative Artificial Intelligence (AI) for its drug development processes. The combination of AI and scalable wet lab technologies allows the company to more rapidly develop more effective drugs.

The Zug Innovation Center brings Absci’s AI-based platform for drug development activities to “the heart of European innovation”, as Sean McClain, founder and CEO of Absci, explains in a press release issued by his company. “Zug is a leading biotech hub for bringing drugs to market. Absci is tapping into its talent and technology ecosystem to realize our mission of bringing life-changing biologics to patients faster, through the power of generative AI and our expansion into the region”, he adds.

The Zug Innovation Center brings Absci’s drug creation platform to the heart of European innovation.
Sean McClain, CEO and Founder Absci, Greater Zurich Area
Sean McClain - Founder & CEO, Absci

This expansion into the European pharma market “signals a new phase in expanding our strategic R&D portfolio and building Absci’s own drug development pipeline”, comments Andreas Busch, Chief Innovation Officer (CIO) at Absci. The selection of Zug as a location will help the company to tap into “important potential partners, global talent, and AI capabilities in Europe and beyond”, Busch concludes.

The new Zug Innovation Center is operated by the wholly owned subsidiary Absci GmbH, which is managed by Christine Lemke and Christian Stegmann. Generative AI has the potential “to power the next era of drug creation”, with Absci set to play a pioneering role in discovering exactly what can be achieved, according to Stegmann. mm

Life Science & Innovation Hub Greater Zurich Area

Life Science & Innovation Hub Greater Zurich Area

The Greater Zurich Area has evolved into a dynamically expanding life sciences hotspot, thanks to the region’s academic excellence, business-friendly regulations, IP protection, large international talent pool and R&D collaborations between universities and start-ups, as well as large multinational corporations.

BioTech Greater Zurich Area

Do you need more insights and data? Reach out!

Milena Lussi Portrait
Milena Lussi
Project Manager Europe, Israel and Key Ecosystems
Lukas Sieber Portrait
Lukas Sieber
Executive Director USA

Contact us

Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center?